StreetInsider.com News Articles

Bio-Techne Corp. (TECH) PT Raised to $68 at Argus

Thu, 12 Mar 2026 06:53:03 -0400

Argus analyst David Toung raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $68.00 (from $65.00) while maintaining a Buy rating.

The analyst comments "Our BUY rating on Bio-Techne Corp. (NGS: TECH) reflects the company's longterm growth opportunities in life sciences, molecular diagnostics, and spatial biology. These opportunities include collaborating with technology partners to harness AIenabled tools to assist in drug discovery and development. While the company faces near-term headwinds, its end markets are displaying signs of improvement. Bio-Techne provides key reagents, proteins and instruments that enable biopharma companies to develop and manufacture biologic therapies. To be sure, the TECH

Bio-Techne Corp. (TECH) PT Raised to $68 at Argus

Thu, 12 Mar 2026 06:53:03 -0400

Argus analyst David Toung raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $68.00 (from $65.00) while maintaining a Buy rating.

Form 3 BIO-TECHNE Corp For: Mar 01 Filed by: Crouse Steven C.

Wed, 04 Mar 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260304/26113314.html

Form 3 BIO-TECHNE Corp For: Mar 01 Filed by: Crouse Steven C.

Wed, 04 Mar 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260304/26113314.html

Form 4 BIO-TECHNE Corp For: Mar 02 Filed by: Crouse Steven C.

Wed, 04 Mar 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260304/26113315.html

Form 4 BIO-TECHNE Corp For: Mar 02 Filed by: Crouse Steven C.

Wed, 04 Mar 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260304/26113315.html

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Bio-Techne to Present at Upcoming Investor Conferences

Tue, 24 Feb 2026 07:00:00 -0400

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing

Form 4 BIO-TECHNE Corp For: Feb 17 Filed by: Herr Amy E.

Thu, 19 Feb 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260219/26030903.html

Form 4 BIO-TECHNE Corp For: Feb 17 Filed by: Herr Amy E.

Thu, 19 Feb 2026 16:58:00 -0400

si-local-file:///var/storage/secattach/20260219/26030903.html

Form 144 BIO-TECHNE Corp Filed by: Herr Amy E.

Tue, 17 Feb 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260217/26013313.html

Form 144 BIO-TECHNE Corp Filed by: Herr Amy E.

Tue, 17 Feb 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260217/26013313.html

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

MINNEAPOLIS , Feb. 16, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced that the Ella benchtop immunoassay platform has received CE-IVD marking¹ and is now available for sale in the European Union. This achievement brings Ella's hallmark ease of use, speed

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

Mon, 16 Feb 2026 06:30:00 -0400

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU
Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with minimal hands-on time
Provides confidence for use in clinical trials and in-house test development